These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II. Koster A; Meyer O; Fischer T; Kukucka M; Krabatsch T; Bauer M; Kuppe H; Hetzer R J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1254-5. PubMed ID: 11726910 [No Abstract] [Full Text] [Related]
3. Specific glycoprotein IIb/IIIa antagonists and inflammation. Ercan E Int J Cardiol; 2004 Mar; 94(1):121-2. PubMed ID: 14996486 [No Abstract] [Full Text] [Related]
12. [Reflections on GPIIb/IIIA inhibitors ... and all around ...]. Neri Serneri GG G Ital Cardiol; 1999 Apr; 29(4):467-71. PubMed ID: 10327329 [No Abstract] [Full Text] [Related]
13. Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban. Hölschermann H; Krombach C; Jung A; Jacobi F; Tillmanns H; Weinand F Thromb Haemost; 2005 Sep; 94(3):684-6. PubMed ID: 16268493 [No Abstract] [Full Text] [Related]
14. [Advance on clinical applications of platelet glycoprotein IIb/IIIa receptor inhibitors]. Zhou P; Yan HB Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):274-7. PubMed ID: 21609538 [No Abstract] [Full Text] [Related]
15. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes. Bolognese L Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721 [TBL] [Abstract][Full Text] [Related]
16. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes. Harrington RA Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670 [TBL] [Abstract][Full Text] [Related]